Literature DB >> 25601933

Effects of continuous positive airway pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant hypertension: a randomized controlled trial.

Elizabeth S Muxfeldt1, Victor Margallo1, Leonardo M S Costa1, Gleison Guimarães1, Aline H Cavalcante1, João C M Azevedo1, Fabio de Souza1, Claudia R L Cardoso1, Gil F Salles2.   

Abstract

The effect of continuous positive airway pressure (CPAP) on blood pressures (BPs) in patients with resistant hypertension and obstructive sleep apnea is not established. We aimed to evaluate it in a randomized controlled clinical trial, with blinded assessment of outcomes. Four hundred thirty-four resistant hypertensive patients were screened and 117 patients with moderate/severe obstructive sleep apnea, defined by an apnea-hypopnea index ≥15 per hour, were randomized to 6-month CPAP treatment (57 patients) or no therapy (60 patients), while maintaining antihypertensive treatment. Clinic and 24-hour ambulatory BPs were obtained before and after 6-month treatment. Primary outcomes were changes in clinic and ambulatory BPs and in nocturnal BP fall patterns. Intention-to-treat and per-protocol (limited to those with uncontrolled ambulatory BPs) analyses were performed. Patients had mean (SD) 24-hour BP of 129(16)/75(12) mm Hg, and 59% had uncontrolled ambulatory BPs. Mean apnea-hypopnea index was 41 per hour and 58.5% had severe obstructive sleep apnea. On intention-to-treat analysis, there was no significant difference in any BP change, neither in nocturnal BP fall, between CPAP and control groups. The best effect of CPAP was on night-time systolic blood pressure in per-protocol analysis, with greater reduction of 4.7 mm Hg (95% confidence interval, -11.3 to +3.1 mm Hg; P=0.24) and an increase in nocturnal BP fall of 2.2% (95% confidence interval, -1.6% to +5.8%; P=0.25), in comparison with control group. In conclusion, CPAP treatment had no significant effect on clinic and ambulatory BPs in patients with resistant hypertension and moderate/severe obstructive sleep apnea, although a beneficial effect on night-time systolic blood pressure and on nocturnal BP fall might exist in patients with uncontrolled ambulatory BP levels.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  continuous positive airway pressure; obstructive sleep apnea; randomized controlled trial; resistant hypertension to conventional therapy

Mesh:

Substances:

Year:  2015        PMID: 25601933     DOI: 10.1161/HYPERTENSIONAHA.114.04852

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  43 in total

Review 1.  The Use of Precision Medicine to Manage Obstructive Sleep Apnea Treatment in Patients with Resistant Hypertension: Current Evidence and Future Directions.

Authors:  Esther Sapiña; Gerard Torres; Ferran Barbé; Manuel Sánchez-de-la-Torre
Journal:  Curr Hypertens Rep       Date:  2018-06-08       Impact factor: 5.369

2.  Metoprolol has a similar therapeutic effect as amlodipine on BP lowering in hypertensive patients with obstructive sleep apnea.

Authors:  Jing Shi; Yue Yuan; Xianzhu Deng; Yujiao Pan; Meijiao He; Guangzhong Liu; Danghui Sun; Jiayu Wang; Wennan Wang; Yue Li
Journal:  Sleep Breath       Date:  2018-06-27       Impact factor: 2.816

3.  Treatment of Adult Obstructive Sleep Apnea With Positive Airway Pressure: An American Academy of Sleep Medicine Systematic Review, Meta-Analysis, and GRADE Assessment.

Authors:  Susheel P Patil; Indu A Ayappa; Sean M Caples; R Joh Kimoff; Sanjay R Patel; Christopher G Harrod
Journal:  J Clin Sleep Med       Date:  2019-02-15       Impact factor: 4.062

4.  Sleep-disordered breathing in the elderly: is it distinct from that in the younger or middle-aged populations?

Authors:  Hiroki Kitakata; Takashi Kohno; Keiichi Fukuda
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

Review 5.  Cardiovascular outcomes of continuous positive airway pressure therapy for obstructive sleep apnea.

Authors:  Yüksel Peker; Baran Balcan
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 6.  Management of Hypertension in Obstructive Sleep Apnea.

Authors:  Sofia F Furlan; Caio V Braz; Geraldo Lorenzi-Filho; Luciano F Drager
Journal:  Curr Cardiol Rep       Date:  2015-12       Impact factor: 2.931

Review 7.  Sleep Duration and Quality: Impact on Lifestyle Behaviors and Cardiometabolic Health: A Scientific Statement From the American Heart Association.

Authors:  Marie-Pierre St-Onge; Michael A Grandner; Devin Brown; Molly B Conroy; Girardin Jean-Louis; Michael Coons; Deepak L Bhatt
Journal:  Circulation       Date:  2016-09-19       Impact factor: 29.690

Review 8.  Obstructive sleep apnea and ambulatory blood pressure monitoring: current evidence and research gaps.

Authors:  Andrea Pio-Abreu; Heitor Moreno; Luciano F Drager
Journal:  J Hum Hypertens       Date:  2021-01-07       Impact factor: 3.012

9.  Obstructive sleep apnea-Hypertension link: almost there?

Authors:  Flavio Danni Fuchs; Sandra C Fuchs; Denis Martinez
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

Review 10.  Obstructive Sleep Apnea and Arterial Hypertension: Implications of Treatment Adherence.

Authors:  Tomás Posadas; Francisco Campos-Rodriguez; Esther Sapiña-Beltrán; Grace Oscullo; Gerard Torres; Miguel Angel Martinez-Garcia
Journal:  Curr Hypertens Rep       Date:  2020-02-03       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.